Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Lambda

Nvidia signs $1.5 billion deal with cloud startup Lambda to rent back its own AI chips — 18,000 GPUs will be leased over 4 years, as Lambda gears up for its IPO

Nvidia, the source of origin for much of the contemporary AI hype, is now looking to rent back its own chips from Lambda. The Green Team is already a heavy investor in the AI startup but will now lease 18,000 GPUs over a 4-year long period, helping Lambda ready up…

Tom’s Hardware

Super Micro Flags Risks That Could Disrupt Results, Stock Falls

Super Micro Computer (NASDAQ:SMCI) warned that weaknesses in its financial disclosure controls could hinder its ability to deliver timely and accurate results if left unaddressed.

Benzinga

Asus brings Nvidia’s GB300 Blackwell Ultra “desktop superchip” to workstations — plain-looking desktop more powerful than most server racks, features up to 784GB of coherent memory, 20 PFLOPS AI performance

Asus has launched the ExpertCenter Pro ET900N G3, a desktop powered by Nvidia’s GB300 Grace Blackwell Ultra, offering up to 20 PFLOPS of AI performance and 784 GB of memory. This marks NVIDIA’s shift from DGX-only systems to OEM desktops, with GB300 servers entering mass production by Q4 2025.

Tom’s Hardware

From analysis to the latest developments in health,
read the most diverse news in one place.

Lambda Legal, a nonprofit supporting LGBTQ+ rights, exceeded fundraising goal by $105M

The legal aid group Lambda Legal has raised $285 million at a time when attacks on the rights of gay, intersex and transgender people have again intensified

The Independent UK

Nvidia unveils DGX Station workstation PCs with GB300 Blackwell Ultra inside

Nvidia reveals GB300 Blackwell Ultra workstation: Asus, Boxx, Dell, HP, Lambda, Lenovo, and Supermicro to carry actual machines.

Tom’s Hardware

Mazda's Skyactiv-Z Will Be 'The Ideal Internal Combustion Engine'

These days, we rarely get to talk about newly developed gas engines. Automakers prefer to hype up their future EVs, while internal combustion becomes little more than a footnote. But some companies are bucking the trend. Mazda defied the downsizing agenda with its gas and diesel inline-sixes, and now it’s…

Motor1

I ruined my gravel bike by trying to make it ‘progressive’ - Don’t make the same mistake as me!

Leave race setups to the pros, you’ll have more fun on a normal gravel bike

Cycling News

Read news from The Economist, FT, and more,
with one subscription

Narrow bars go mainstream, new Vittoria tyres, and more affordable carbon wheels: Six tech snippets from iceBike

What’s coming up from some of the sport’s biggest brands in 2025?

Cycling News

My gravel race super build: The Ridley ASTR RS with super-wide wheels and narrow bars

A subtle build with progressive components and top-level spec

Cycling News

Mozambique’s transgender history is on display in a powerful photo exhibition

A pioneering queer photo exhibition that was staged 20 years ago in Mozambique and South Africa has found new life and a new audience. Manas 2000-2024, by the Danish photographer Ditte Haarløv Johnsen, opened at the French-Mozambican Cultural Centre, in the capital Maputo, on 8 July. The show kicked off…

The Conversation

I tried 22cm road bars and lived to tell the tale: A review of the Lambda X-Wing bars

Despite what the comments section would have you believe, they’re actually fine, and I’d even say I like them

Cycling News

Judges pull award nomination for book by Lauren Hough

The author of an acclaimed debut essay collection has had a prominent LGBTQ literary nomination withdrawn

The Independent UK

Lambda Literary Awards Reject LGBTQ Author After She Defended a Friend Accused of Transphobia

"I am a queer woman, and I was silenced most of my life," writes Lauren Hough, author of Leaving Isn't the Hardest Thing.

Reason

Why Eiger BioPharmaceuticals Stock Is Jumping Today

Eiger BioPharmaceuticals Inc (NASDAQ: EIGR) announced data from the Phase 3 TOGETHER study evaluating Peginterferon Lambda in non-hospitalized COVID-19 adult patients at high risk of progressing to severe illness.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.